Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 242, Issue 10, 2004, Pages 814-818

  Akarsu, Cengiz ^a,b   Yılmaz, Sevda ^b   Taner, Pelin ^b   Ergin, Ahmet ^b  

^a University of Kirikkale ^*  (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CILIARY ARTERY; CLINICAL ARTICLE; CLINICAL STUDY; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; OPHTHALMIC ARTERY; PALPATION; PRIORITY JOURNAL; RETINA ARTERY; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

EID: 8444235553     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-004-0906-y     Document Type: Article

References (35)

1. Akarsu C, Bilgili MYK (2004) Color Doppler imaging in ocular hypertension and open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 242:125-129
2. Allemann R, Flammer J, Haefliger IO (2003) Vasoactive properties of bimatoprost in isolated porcine ciliary arteries. Klin Monatsbl Augenheilkd 220:161-164 10.1055/s-2003-38167, 12664371
3. Brandt JD, VanDenburgh AM, Chen K, Whitcup SM, for the Bimatoprost Study Group 1 (2001) Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: A 3-month clinical trial. Ophthalmology 108:1023-1032 10.1016/S0161-6420(01)00584-X, 1:STN:280:DC%2BD3M3pvFekug%3D%3D, 11382623
4. Brubaker RF, Schoff EO, Nau CB, Carpenter SP, Chen K, VanDenburgh AM (2001) Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am J Ophthalmol 131:19-24 10.1016/S0002-9394(00)00843-6, 1:CAS:528:DC%2BD3MXksVCmtQ%3D%3D, 11162974
5. Chung HS, Harris A, Evans DW, Kagemann L, Garzozi HJ, Martin B (1999) Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol 43 [Suppl 1]:S43-S50
6. Costa VP, Harris A, Stefansson E, Flammer J, Krieglstein GK, Orzalesi N, Heijl A, Renard JP, Serra LM (2003) The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res 22:769-805. 10.1016/S1350-9462(03)00064-8, 1:CAS:528:DC%2BD3sXot1GlsLg%3D, 14575724
7. Collignon-Brach J (1992) Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma. Curr Eye Res 11:1-3. 1:STN:280:By2B3MjjsFY%3D
8. Gandolfi S, Simmons ST, Sturm R, Chen K, VanDenburgh AM, for the Bimatoprost Study Group 3 (2001) Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther 18:110-121. 1:CAS:528:DC%2BD3MXntFGqtL4%3D, 11571823
9. Hansen NB, Stonestreet BS, Rosenkrantz TS, Oh W (1983) Validity of Doppler measurements of anterior cerebral artery blood flow velocity: correlation with brain blood flow in piglets. Pediatrics 72:526-531. 1:STN:280:BiyB1MbgvFI%3D, 6889067
10. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WLM (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603-624. 1:STN:280:ByuB38nisVI%3D, 8172267
11. Hellberg MR, Ke TL, Haggard K, Klimko PG, Dean TR, Graff G (2003) The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2alpha by human and rabbit ocular tissue. J Ocul Pharmacol Ther 19:97-103. 10.1089/108076803321637627, 1:CAS:528:DC%2BD3sXjsFejurk%3D, 12804054
12. Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K, Whitcup SM, for the bimatoprost study groups 1 and 2 (2002) One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol 120:1286-1293. 1:CAS:528:DC%2BD38Xoslyisrk%3D, 12365906
13. Joyner WL, Gilmore JP (1986) Tissues grafted into the cheek pouch of the hamster. In: Baker CH, Nastuk WL (eds) Microcirculatory technology. Physical techniques in biology and medicine. Academic Press, London, pp 3-17
14. Kaiser HJ, Flammer J, Stumpfig D, Hendrickson P (1994) Long-term visual field follow-up of glaucoma patients treated with beta-blockers. Surv Ophthalmol 38 [Suppl 1]:S156-S160
15. Kaiser HJ, Schoetzau A, Stumpfig D, Flammer J (1997) Blood-flow velocities of the extraocular vessels in patients with high-tension and normal-tension primary open-angle glaucoma. Am J Ophthalmol 123:320-327. 1:STN:280:ByiB3Mjit1Q%3D, 9063241
16. Laibovitz RA, VanDenburgh AM, Felix C, David R, Batoosingh A, Rosenthal A, Cheetham J (2001) Comparison of the ocular hypotensive lipid AGN 192024 with timolol: Dosing, efficacy, and safety evaluation of a novel compound for glaucoma management. Arch Ophthalmol 119:994-1000. 1:CAS:528:DC%2BD3MXlslSlsb0%3D, 11448321
17. Maxey KM, Johnson J, LaBrecque J (2002) The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist. Surv Ophthalmol 47 [Suppl 1]:S34-S40
18. Messmer C, Flammer J, Stumpfig D (1991) Influence of betaxolol and timolol on the visual field of patients with glaucoma. Am J Ophthalmol 112;678-681
19. Nicolela MT, Buckley AR, Walman BE, Drance SM (1996) A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels. Am J Ophthalmol 122:784-789. 1:CAS:528:DyaK2sXisFCksA%3D%3D, 8956632
20. Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM, for the bimatoprost/latanoprost study group (2003) A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 135:55-63. 10.1016/S0002-9394(02)01827-5, 1:CAS:528:DC%2BD38XpslSlu78%3D, 12504698
21. Parrish RK, Palmberg P, Sheu WP, for the XLT study group (2003) A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 135:688-703. 10.1016/S0002-9394(03)00098-9, 1:CAS:528:DC%2BD3sXjt1KnsbY%3D, 12719078
22. Rankin SJA (1999) Color Doppler imaging of the retrobulbar circulation in glaucoma. Surv Ophthalmol 1999;43:176-182
23. Resul B, Stjernschantz J, Selen G, Bito LZ (1997) Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids. Surv Ophthalmol 41:S47-S52. 9154276
24. Satilmiş M, Orgül S, Doubler B, Flammer J (2003) Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure. Am J Ophthalmol 135:664-669. 10.1016/S0002-9394(02)02156-6, 12719074
25. Schumann J, Orgül S, Gugleta K, Dubler B, Flammer J (2000) Interocular difference in progression of glaucoma correlates with interocular differences in retrobulbar circulation. Am J Ophthalmol 129:728-733. 10.1016/S0002-9394(99)00481-X, 1:STN:280:DC%2BD3cvhs1eqtA%3D%3D, 10926980
26. Seong GJ, Lee HK, Hong YJ (1999) Effects of 0.005% latanoprost on optic nerve head and peripapillary retinal blood flow. Ophthalmologica 213:355-359. 1:CAS:528:DyaK1MXotVSgsrw%3D, 10567866
27. Sergott RC, Aburn NS, Trible JR, Costa VP, Lieb WE Jr, Flaharty PM (1994) Color Doppler imaging: Methodology and preliminary results in glaucoma. Surv Ophthalmol 38 [Suppl 1]:S65-S71
28. Sharif NA, Williams GW, Kelly CR (2001) Bimatoprost and its free acid are prostaglandin FP receptor agonists. Eur J Pharmacol 432:211-213. 10.1016/S0014-2999(01)01486-8, 1:CAS:528:DC%2BD3MXptVSktbo%3D, 11740958
29. Stjernschantz J, Selen G, Astin M, Karlsson M, Resul B (1999) Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye. Arch Ophthalmol 117:1363-1367. 1:CAS:528:DyaK1MXntVWgtrw%3D, 10532445
30. 2α- isopropyl ester to latanoprost: A review of the develTpment of xalatan: the Proctor lecture. Invest Ophthalmol Vis Sci 42:1134-1145. 1:STN:280:DC%2BD3M3kvFKqsg%3D%3D, 11328719
31. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC (1995) Hypertension, perfusion pressure and primary open-angle glaucoma. Arch Ophthalmol 113:216-221. 1:STN:280:ByqC28fpvFM%3D, 7864755
32. Whitcup SM, Cantor LB, VanDenburg AM, Chen K, for the bimatoprost study Group II (2003) A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension. Br J Ophthalmol 87:57-62. 10.1136/bjo.87.1.57, 1:STN:280:DC%2BD38jisFGgug%3D%3D, 12488264
33. Williamson TH, Harris A (1996) Color Doppler ultrasound imaging of the eye and orbit. Surv Ophthalmol 40:255-267. 1:STN:280:BymB3MvmsV0%3D, 8658337
34. Woodward DF, Krauss AHP, Chen J, Lai RK, Spada CS, Burk RM, Andrews SW, Shi L, Liang Y, Kedzie KM, Chen R, et al (2001) The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol 45 [Suppl 4]:S337-S345
35. Yamazaki Y, Drance SM (1997) The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am J Ophthalmol 124:287-295. 1:STN:280:DyaK1c7gt1Cltg%3D%3D, 9439354